Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2 00:10:00

Share On Facebook Share On Twitter

Rohan Palekar is the Chief Executive Officer and a member of the Board of Directors at 89bio, Inc., leading the company since June 2018. With over 30 years of industry experience, Palekar previously held leadership roles at Avanir Pharmaceuticals and Medivation. 89bio focuses on developing treatments for liver and cardiometabolic diseases.

Recent Videos